ProfileGDS4718 / 202591_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 96% 94% 96% 94% 94% 98% 99% 96% 93% 96% 97% 94% 98% 98% 99% 96% 95% 98% 98% 96% 96% 96% 96% 96% 96% 98% 95% 98% 94% 98% 98% 98% 92% 94% 98% 98% 98% 95% 95% 96% 95% 98% 97% 99% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.642696
GSM549102patient 115, normal, homogenized [OPG study]10.051794
GSM549104patient 119, normal, homogenized [OPG study]10.578596
GSM549108patient 138, normal, homogenized [OPG study]10.063594
GSM549119patient 077, normal, homogenized [OPG study]10.000694
GSM549133patient 032, cancer, homogenized [OPG study]11.839898
GSM549139patient 042, cancer, homogenized [OPG study]11.846799
GSM549099patient 107, normal, homogenized [OPG study]10.489696
GSM549109patient 139, normal, homogenized [OPG study]9.8126393
GSM549110patient 046, normal, homogenized [OPG study]10.688696
GSM549114patient 063, normal, homogenized [OPG study]11.059597
GSM549122patient 082, normal, homogenized [OPG study]10.083994
GSM549134patient 033, cancer, homogenized [OPG study]11.596198
GSM549136patient 036, cancer, homogenized [OPG study]11.452798
GSM549140patient 044, cancer, homogenized [OPG study]11.774299
GSM549111patient 047, normal, homogenized [OPG study]10.748596
GSM549113patient 057, normal, homogenized [OPG study]10.539595
GSM549132patient 031, cancer, homogenized [OPG study]11.121998
GSM549137patient 038, cancer, homogenized [OPG study]11.046998
GSM549142patient 047, cancer, homogenized [OPG study]9.8689196
GSM549100patient 110, normal, homogenized [OPG study]10.642796
GSM549107patient 135, normal, homogenized [OPG study]10.613196
GSM549115patient 068, normal, homogenized [OPG study]10.658296
GSM549116patient 072, normal, homogenized [OPG study]10.578496
GSM549120patient 078, normal, homogenized [OPG study]10.524496
GSM549131patient 030, cancer, homogenized [OPG study]11.583498
GSM549118patient 074, normal, homogenized [OPG study]10.189295
GSM549129patient 027, cancer, homogenized [OPG study]11.017798
GSM549123patient 088, normal, homogenized [OPG study]10.097994
GSM549124patient 006, cancer, homogenized [OPG study]11.446298
GSM549126patient 015, cancer, homogenized [OPG study]11.038198
GSM549128patient 025, cancer, homogenized [OPG study]11.374498
GSM549103patient 117, normal, homogenized [OPG study]9.4715892
GSM549117patient 073, normal, homogenized [OPG study]10.268294
GSM549138patient 041, cancer, homogenized [OPG study]11.563598
GSM549141patient 045, cancer, homogenized [OPG study]11.758298
GSM549130patient 028, cancer, homogenized [OPG study]11.315798
GSM549101patient 111, normal, homogenized [OPG study]10.226895
GSM549105patient 128, normal, homogenized [OPG study]10.326995
GSM549106patient 134, normal, homogenized [OPG study]10.782796
GSM549112patient 048, normal, homogenized [OPG study]10.504295
GSM549125patient 011, cancer, homogenized [OPG study]11.246398
GSM549127patient 024, cancer, homogenized [OPG study]10.863897
GSM549135patient 035, cancer, homogenized [OPG study]11.891699